A combined crystalloid and colloid PD solution as a glucose-sparing strategy for volume control in high-transport Apd Patients: A prospective multicenter study

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 433-442

  Freida, Philippe ^a   Issad, Belkacem ^b   Dratwa, Max ^c   Lobbedez, Thierry ^d   Wu, Lieling ^e   Leypoldt, John K ^e   Divino Filho, Jose Carolino ^f,g  

^a Registre des cancers de La Manche(ARKM)   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^d CHU Clemenceau   (France)

^e BAXTER HEALTHCARE CORPORATION   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g Baxter Renal Division Latin America   (Mexico)

Author keywords

Bimodal ultrafiltration; Fluid and sodium removal; Glucose exposure; Glucose sparing

Indexed keywords

COLLOID PERITONEAL DIALYSIS FLUID; CRYSTALLOID PERITONEAL DIALYSIS FLUID; GLUCOSE; ICODEXTRIN; PERITONEAL DIALYSIS FLUID; SODIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; FEMALE; GLUCOSE ABSORPTION; HUMAN; MALE; MULTICENTER STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; ULTRAFILTRATION;

EID: 70349512987     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900410     Document Type: Article

References (25)

1. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
2. Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl 2006; 103: S104-9.
3. Davies SJ, Garcia Lopez E, Woodrow G, Donovan K, Plum J, Williams P, et al. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. Nephrol Dial Transplant 2008; 23:2982-8.
4. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
5. Rodriguez-Carmona A, Perez Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-45.
6. Jenkins S, Wilkie M. Mixing osmotic agents - two different approaches. Perit Dial Int 2007; 27:245-50.
7. Rodriguez-Carmona A, Perez Fontan M, Garcia Lopez E, Garcia Falcon T, Diaz Cambre H. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study. Perit Dial Int 2007; 27: 260-6.
8. Dallas F, Jenkins SB, Wilkie ME. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study. Perit Dial Int 2004; 24:542-6.
9. Faller B, Shockley T, Genestier S, Martis L. Polyglucose and amino acids: preliminary results. Perit Dial Int 1997; 17(Suppl 2):S63-7.
10. Freida P, Galach M, Divino Filho JC, Werynski A, Lindholm B. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell. Perit Dial Int 2007; 27:267-76.
11. Jenkins SB, Wilkie ME. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone. Perit Dial Int 2003; 23:475-80.
12. Freida P, Wilkie M, Jenkins S, Dallas F, Issad B. The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis. Kidney Int Suppl 2008; 108:S102-11.
13. Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int Suppl 2006; 103:S76-83.
14. Davies SJ, Brown EA, Reigel W, Clutterbuck E, Heimburger O, Diaz NV, et al. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26:458-65.
15. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
16. Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001; 17:80-3.
17. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-94.
18. Holmes CJ, Shockley TR. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int 2000; 20(Suppl 2):S37-41.
19. FAO/WHO. Carbohydrates in human nutrition: report of a joint FAO/WHO expert consultation. FAO Food Nutr Pap 1998; 66:1-140.
20. Aanen MC, Venturoli D, Davies SJ. A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function. Nephrol Dial Transplant 2005; 20:1192-200.
21. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
22. Struijk DG, Krediet RT. Sodium balance in automated peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 2):S101-5.
23. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948-57.
24. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
25. Konings CJ, Kooman JP, Gladziwa U, van der Sande FM, Leunissen KM. A decline in residual glomerular filtration during the use of icodextrin may be due to underhydration. Kidney Int 2005; 67:1190-1.